Under construction – not a live service

Skip to content

Frontlight Research

Trial site

ICIMED (Site 0552)

San José, Costa RicaNot linked to an institution yet

1running trials
0closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Recruiting
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
NCT06312176· Phase 3· Source

Researchers

No researcher is linked here yet.

Site data: ClinicalTrials.govUpdated 3 Nov 2026

Report an error

Under construction, not live – ICIMED (Site 0552): trial site – Frontlight Research